Merck & Co Inc
1MRKX
Company Profile
Business description
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
Contact
126 East Lincoln Avenue
RahwayNJ07065
USAT: +1 908 740-4000
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2025
Employees
75,000
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,571.40 | 40.30 | -0.47% |
CAC 40 | 7,814.39 | 96.10 | -1.21% |
DAX 40 | 23,889.52 | 232.88 | -0.97% |
Dow JONES (US) | 41,802.92 | 57.52 | -0.14% |
FTSE 100 | 8,697.01 | 89.45 | -1.02% |
HKSE | 23,544.31 | 283.47 | -1.19% |
NASDAQ | 18,899.09 | 26.45 | 0.14% |
Nikkei 225 | 36,985.87 | 313.11 | -0.84% |
NZX 50 Index | 12,662.25 | 40.85 | -0.32% |
S&P 500 | 5,836.51 | 8.10 | -0.14% |
S&P/ASX 200 | 8,348.70 | 38.10 | -0.45% |
SSE Composite Index | 3,380.19 | 7.39 | -0.22% |